Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study

Akbar K Waljee; Peter D R Higgins; Camilla B Jensen; Marie Villumsen; Shirley A Cohen-Mekelburg; Beth I Wallace; Jeffrey A Berinstein; Kristine H Allin; Tine Jess

doi:10.1016/S2468-1253(19)30362-0

Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study

Akbar K Waljee, Peter D R Higgins, Camilla B Jensen, Marie Villumsen, Shirley A Cohen-Mekelburg, Beth I Wallace, Jeffrey A Berinstein, Kristine H Allin, Tine Jess

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The Lancet Gastroenterology & Hepatology
Vol/bind	5
Udgave nummer	3
Sider (fra-til)	276-284
Antal sider	9
ISSN	2468-1253
DOI	https://doi.org/10.1016/S2468-1253(19)30362-0
Status	Udgivet - mar. 2020

Adgang til dokumentet

10.1016/S2468-1253(19)30362-0

http://www.scopus.com/inward/record.url?scp=85079410468&partnerID=8YFLogxK

Fingeraftryk Dyk ned i forskningsemnerne om 'Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Waljee, A. K., Higgins, P. D. R., Jensen, C. B., Villumsen, M., Cohen-Mekelburg, S. A., Wallace, B. I., Berinstein, J. A., Allin, K. H., & Jess, T. (2020). Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study. The Lancet Gastroenterology & Hepatology, 5(3), 276-284. https://doi.org/10.1016/S2468-1253(19)30362-0

Waljee, Akbar K ; Higgins, Peter D R ; Jensen, Camilla B ; Villumsen, Marie ; Cohen-Mekelburg, Shirley A ; Wallace, Beth I ; Berinstein, Jeffrey A ; Allin, Kristine H ; Jess, Tine. / Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark : a nationwide, population-based cohort study. I: The Lancet Gastroenterology & Hepatology. 2020 ; Bind 5, Nr. 3. s. 276-284.

@article{596056d84c4f402cb8287df452652074,

title = "Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study",

author = "Waljee, {Akbar K} and Higgins, {Peter D R} and Jensen, {Camilla B} and Marie Villumsen and Cohen-Mekelburg, {Shirley A} and Wallace, {Beth I} and Berinstein, {Jeffrey A} and Allin, {Kristine H} and Tine Jess",

year = "2020",

month = mar,

doi = "10.1016/S2468-1253(19)30362-0",

language = "English",

volume = "5",

pages = "276--284",

journal = "The Lancet Gastroenterology & Hepatology",

issn = "2468-1253",

publisher = "Elsevier",

number = "3",

}

Waljee, AK, Higgins, PDR, Jensen, CB, Villumsen, M, Cohen-Mekelburg, SA, Wallace, BI, Berinstein, JA, Allin, KH & Jess, T 2020, 'Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study', The Lancet Gastroenterology & Hepatology, bind 5, nr. 3, s. 276-284. https://doi.org/10.1016/S2468-1253(19)30362-0

Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark : a nationwide, population-based cohort study. / Waljee, Akbar K; Higgins, Peter D R; Jensen, Camilla B; Villumsen, Marie; Cohen-Mekelburg, Shirley A; Wallace, Beth I; Berinstein, Jeffrey A; Allin, Kristine H; Jess, Tine.

I: The Lancet Gastroenterology & Hepatology, Bind 5, Nr. 3, 03.2020, s. 276-284.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark

T2 - a nationwide, population-based cohort study

AU - Waljee, Akbar K

AU - Higgins, Peter D R

AU - Jensen, Camilla B

AU - Villumsen, Marie

AU - Cohen-Mekelburg, Shirley A

AU - Wallace, Beth I

AU - Berinstein, Jeffrey A

AU - Allin, Kristine H

AU - Jess, Tine

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079410468&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(19)30362-0

DO - 10.1016/S2468-1253(19)30362-0

M3 - Journal article

C2 - 31836320

VL - 5

SP - 276

EP - 284

JO - The Lancet Gastroenterology & Hepatology

JF - The Lancet Gastroenterology & Hepatology

SN - 2468-1253

IS - 3

ER -

Waljee AK, Higgins PDR, Jensen CB, Villumsen M, Cohen-Mekelburg SA, Wallace BI et al. Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study. The Lancet Gastroenterology & Hepatology. 2020 mar;5(3):276-284. https://doi.org/10.1016/S2468-1253(19)30362-0